Delivery Order SPE2DB22D2206-SPE2DB25FHT52

Award Date 7/3/25
Potential Completion Date 7/25/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,376.46 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $4,917.64 with a firm fixed price and an ultimate completion date of June 16, 2025. The contract is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.70 firm-fixed-price delivery order is for the supply of the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a period of performance through July 16, 2025. The contract is not set-aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, covers the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The $2,376.70 firm fixed price delivery order contract has a period of performance through December 4, 2024 and was awarded on November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,130.04 firm fixed price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The award is not associated with a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML medication. The $2,458.82 Firm Fixed Price delivery order was awarded by the Defense Logistics Agency (DLA) on December 13, 2024, with a completion date of January 7, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHT52
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 firm fixed price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a prescription medication. The contract has an ultimate completion date of July 25, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. As a major pharmaceutical supplier to federal agencies, Amerisourcebergen Drug Corp fulfills diverse medical product requirements, including medications across multiple therapeutic areas as well as specialized medical supplies.

Generated 10/2/25, 10:47 AM